newsfilter
← Latest News
GlobeNewswire·

Stemline Therapeutics Reports Third Quarter 2019 Financial Results

Net revenue for ELZONRIS® was $13.3 million for the third quarterNew patient starts estimated to have increased greater than 20% from last quarterConference call and live webcast scheduled for...